Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: |
Title | Regenerative Medicines - Stem Cell Therapy |
Description | Toggle navigation About Us Our Work Our Partnerships Resources Events Presentations Press Releases Press Coverage Get In Touch Professor Sir Martin Evans |
Keywords | N/A |
WebSite | celixir.com |
Host IP | 82.165.135.179 |
Location | United States |
Site | Rank |
US$2,386,819
Last updated: 2023-05-15 08:25:36
celixir.com has Semrush global rank of 4,434,481. celixir.com has an estimated worth of US$ 2,386,819, based on its estimated Ads revenue. celixir.com receives approximately 275,403 unique visitors each day. Its web server is located in United States, with IP address 82.165.135.179. According to SiteAdvisor, celixir.com is safe to visit. |
Purchase/Sale Value | US$2,386,819 |
Daily Ads Revenue | US$2,204 |
Monthly Ads Revenue | US$66,097 |
Yearly Ads Revenue | US$793,159 |
Daily Unique Visitors | 18,361 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
celixir.com. | A | 14400 | IP: 82.165.135.179 |
celixir.com. | NS | 14400 | NS Record: ns.123-reg.co.uk. |
celixir.com. | NS | 14400 | NS Record: ns2.123-reg.co.uk. |
celixir.com. | MX | 14400 | MX Record: 20 celixir-com.mail.protection.outlook.com. |
celixir.com. | TXT | 14400 | TXT Record: MS=ms76093262 |
celixir.com. | TXT | 14400 | TXT Record: v=spf1 ip4:82.165.135.179 ip4:89.197.4.122 include:spf.protection.outlook.com -all |
celixir.com. | TXT | 14400 | TXT Record: v=spf1 ip4:82.165.135.179 ip4:89.197.4.122 include:spf.protection.outlook.com -all |
Toggle navigation About Us Our Work Our Partnerships Resources Events Presentations Press Releases Press Coverage Get In Touch Professor Sir Martin Evans Celixir announces US FDA... Stratford-upon-Avon, 8 June 2018 Alumni Voices: Ajan Reginald We are passionate about advancing ground-breaking regenerative... About Us Our team of world-class scientists and biotechnology leadership is devoted to discovering breakthrough medicines that change the standard of medical care for patients. Sir Martin Evans, Nobel Laureate, and Ajan Reginald, former Global Head of Emerging Technologies at Roche, originally founded the company under the name Cell Therapy Ltd (CTL) in 2009. CTL was rebranded as Celixir in 2016. Press Releases Celixir announces US FDA approval of the IND application for cell therapy HeartcellTM Stratford-upon-Avon, 8 June 2018 Hockey For Heroes Renews Sponsorship with Celixir Stratford upon Avon, 12 March 2018 Presentations 11th World Congress of Regenerative Medicine & Stem Cell |
HTTP/1.1 302 Found Server: nginx Date: Mon, 27 Dec 2021 08:42:13 GMT Content-Type: text/html; charset=iso-8859-1 Connection: keep-alive Location: https://www.celixir.com/ X-Powered-By: PleskLin HTTP/2 200 server: nginx date: Mon, 27 Dec 2021 08:42:13 GMT content-type: text/html; charset=UTF-8 content-length: 49579 last-modified: Wed, 25 Nov 2020 07:42:36 GMT etag: "c1ab-5b4e99229bb27" accept-ranges: bytes vary: Accept-Encoding referrer-policy: x-powered-by: PleskLin |
Domain Name: CELIXIR.COM Registry Domain ID: 1797642077_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.123-reg.co.uk Registrar URL: http://www.meshdigital.com Updated Date: 2021-04-22T06:44:44Z Creation Date: 2013-04-29T18:18:30Z Registry Expiry Date: 2026-04-29T18:18:30Z Registrar: 123-Reg Limited Registrar IANA ID: 1515 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS.123-REG.CO.UK Name Server: NS2.123-REG.CO.UK DNSSEC: unsigned >>> Last update of whois database: 2021-12-29T07:51:36Z <<< |